However, heightened PD-L1 expression diminishes T-cell-mediated cytotoxicity, facilitating evasion from the immune system (14).Tumor-infiltrating lymphocytes (TILs) stand out as the principal effector cells within the tumor tissue microenvironment, expressing PD-1 (15). The gene discussed is CD274; the disease is neoplasm.